Indeed, we found that SCAMP1 expression correlated with Mtss1 expression in tumours with the HER2+/ER−/PR− phenotype and its expression was decreased similarly to MTSS1 in the HER2+/ER−/PR− breast cancer class. This evidence concerns the gene ERBB2 and breast cancer.